About Cryoport
Cryoport is a company based in Brentwood (United States) founded in 2019. It operates as a Managed Services and Direct-to-Consumer (D2C). The company has 1,190 employees as of December 31, 2024. Cryoport offers products and services including Cryogenic Storage Systems, Temperature-Controlled Supply Chain Solutions, and Biostorage and Sample Processing. Cryoport operates in a competitive market with competitors including GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
- Headquarter Brentwood, United States
- Employees 1190 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cryoport, Inc.
-
Annual Revenue
$228.38 M (USD)-2.09as on Dec 31, 2024
-
Net Profit
-$114.76 M (USD)-15.23as on Dec 31, 2024
-
EBITDA
-$37.25 M (USD)-19.55as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
1190
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cryoport
Cryoport is a publicly listed company on the NASDAQ with ticker symbol CYRX in USA, operating in the Transportation sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cryoport
Cryoport offers a comprehensive portfolio of products and services, including Cryogenic Storage Systems, Temperature-Controlled Supply Chain Solutions, and Biostorage and Sample Processing.
Cryogenic storage systems are manufactured for life sciences.
Temperature-controlled solutions are provided for life sciences.
Biostorage and processing services are offered for research.
Funding Insights of Cryoport
Investments & Acquisitions by Cryoport
Financial Statements - Cryoport
Cryoport Comparisons
Competitors of Cryoport
Cryoport operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| domain | founded_year | HQ Location |
Provider of a biorepository of human clinical specimens
|
|
| domain | founded_year | HQ Location |
Human biological materials for research are supplied via a biorepository.
|
|
| domain | founded_year | HQ Location |
Provider of biobanking services for life sciences industries
|
|
| domain | founded_year | HQ Location |
A blockchain-based platform for tokenizing and incentivizing stem cell donations
|
|
| domain | founded_year | HQ Location |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
Frequently Asked Questions about Cryoport
Cryoport was founded in 2019.
Cryoport is headquartered in Brentwood, United States.
Jerrell W Shelton is the current CEO of Cryoport.
As of Dec 31, 2024, the latest employee count at Cryoport is 1,190.
Annual revenue of Cryoport is $228.38M as on Dec 31, 2024.
Cryoport, Inc. is established as a key player in the life sciences sector, specializing in temperature-controlled supply chain solutions. The company is known as the worlds largest manufacturer of cryogenic storage systems. It is also a leader in supporting clinical trials and commercial therapies for regenerative medicine. Additionally, trusted biostorage and sample processing services are provided. Operations span across the Americas, EMEA, and APAC regions with over 15 locations worldwide. Services are extended to biopharmaceutical, animal husbandry, and reproductive medicine companies, as well as universities, research institutions, and government agencies. Innovative supply-chain technologies and services are delivered through industry-leading brands like Cryoport Systems, MVE Biological Solutions, and CRYOGENE.
Cryoport's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Cryoport offers Cryogenic Storage Systems, Temperature-Controlled Supply Chain Solutions, and Biostorage and Sample Processing.
Yes, Cryoport is publicly traded on NASDAQ under the ticker symbol CYRX.
The ticker symbol of Cryoport is CYRX on NASDAQ.